References
- Solal-Céligny P, Roy P, Colombat P, . Follicular Lymphoma International Prognostic Index. Blood 2004;104:1258–1265.
- Buske C, Hoster E, Dreyling M, . The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome. Blood 2006;108:1504–1508.
- Dave SS, Wright G, Tan B, . Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. New Engl J Med 2004;351:2159–2169.
- Yang Z-Z, Grote DM, Ziesmer SC, . Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma. Blood 2011;118:2809–2820.
- Labidi S, Ménétrier-Caux C, Chabaud S, . Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival. Ann Hematol 2010;89:25–33.
- Kelley T, Beck R, Absi A, . Biologic predictors in follicular lymphoma: importance of markers of immune response. Leuk Lymphoma 2007;48:2403–2411.
- Sweetenham JW, Goldman B, LeBlanc ML, . Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study. Ann Oncol 2010;21:1196–1202.
- Wilcox RA, Ristow K, Habermann TM, . The absolute monocyte count predicts overall survival in patients newly diagnosed with follicular lymphoma. Leuk Lymphoma 2011;53:575–580.
- Wilcox RA, Ristow K, Habermann TM, . The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia 2011;25:1502–1509.
- Porrata LF, Ristow K, Colgan J, . Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin lymphoma. Haematologica 2012;97:262–269.
- Tadmor T, Schliamser L, Laor R, . Peripheral blood monocytosis is an independent prognostic factor for survival in diffuse large B cell lymphoma (DLBCL). Ann Oncol 2011;22(Suppl. 4): Abstract 441.
- Andjelic B, Mihaljevic B, Todorovic M, . The number of lymphoma-associated macrophages in tumor tissue is an independent prognostic factor in patients with follicular lymphoma. Appl Immunohistochem Mol Morphol. 2012;20:41–46.
- Tadmor T, Attias D, Polliack A. Myeloid-derived suppressor cells – their role in haemato-oncological malignancies and other cancers and possible implications for therapy. Br J Haematol 2011;153:557–567.
- Lin Y, Gustafson MP, Bulur PA, . Immunosuppressive CD14 + HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma. Blood 2011;20;117:872–881.
- Fell R, Attias D, Polliack A, . Monocytic-myeloid derived suppressor cells (M-MDSC) and their prevalence in the peripheral blood of patients with diffuse large B cell lymphoma (DLBCL). Ann Oncol 2011;22(Suppl. 4): Abstract 388.